Table 2.
Summary of clinical phenotype data for SCD patients used in miRNA microarray analysis
| Subject group | Hb (g/l) | Hct (%) | Platelets (×109/l) | WBC (×109/l) | Neut (×109/l) | Lymph (×109/l) | Retic count (%) |
|---|---|---|---|---|---|---|---|
| High HbF (n = 6) | 86·3 ± 4·9 | 26·11 ± 1·42 | 404·67 ± 60·17 | 11·7 ± 2·00 | 5·2 ± 0·72 | 4·917 ± 1·25 | 8·467 ± 1·15 |
| Low HbF (n = 6) | 78·0 ± 13·0 | 24·13 ± 1·56 | 521 ± 54·35 | 12·95 ± 0·94 | 6·35 ± 0·73 | 4·750 ± 0·59 | 9·783 ± 1·42 |
| P‐values | 0·1766 | 0·3698 | 0·1802 | 0·5943 | 0·2876 | 0·9067 | 0·4353 |
Hb, haemoglobin; Hct, haematocrit; Lymph, lymphocytes; Neut, neutrophils; Retic, reticulocytes; WBC, white blood cells.
P < 0·05 is considered significant.